Antikankerfonds-Fonds Anticancer-Anticance… Fondation
11.4 FTEAntikankerfonds-Fonds Anticancer-Anticance… reported total assets of €5.99m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Jun 2026), with 11.4 full-time equivalents.
By total assets for 2025, Antikankerfonds-Fonds Anticancer-Anticance… ranks among the 200 largest of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Antikankerfonds-Fonds Anticancer-Anticance… shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +38 % Total assets +46 % Headcount (avg FTE) +31 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Antikankerfonds-Fonds Anticancer-Anticance…'s annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 17 Jun 2026
- Year ended 31 Dec 2024filed on 10 Jun 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 10 Jul 2023
- Year ended 31 Dec 2021filed on 15 Jun 2022
Antikankerfonds-Fonds Anticancer-Anticance…'s financial analysis
- Solvency88.8%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Antikankerfonds-Fonds Anticancer-Anticance…
5 active director(s) in the register.
Antikankerfonds-Fonds Anticancer-Anticance…'s shareholders and holdings →Antikankerfonds-Fonds Anticancer-Anticance…'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0535.868.481
- VAT number
- BE0535868481
- Peppol
- Registered · 0208:0535868481 · as of 10 Nov 2026
- Legal form
- Fondation
- Incorporated
- 21 Jun 2013
- Registered office
- 1860 Meise
- Size
- Small · 11.4 FTE
- Latest accounts
- 2025 · filed on 17 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
Antikankerfonds-Fonds Anticancer-Anticance… (Fondation) has been based in Meise since 2013, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 584,413 € and equity of €5.32m; its revenue is not published. With 11.4 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 88.8%, above the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Antikankerfonds-Fonds Anticancer-Anticance…
Companies in the same business, of comparable size and area, outside its group.
- Coherence All other professional, scientific and technical activities n.e.c. Ixelles · balance sheet 80,498 €
- Stellaris Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.53m
- Climate Lab Business and other management consultancy activities Ghent · balance sheet €2.44m
- Agence Prévention et Sécurité Engineering activities and related technical consultancy Marche-en-Famenne · balance sheet 374,629 €
- DECOCK & Co Research and experimental development on natural sciences and engineering Langemark-Poelkapelle · balance sheet €1.31m
- NineSigma Europe Business and other management consultancy activities Leuven · balance sheet €1.10m
- Infraneo Research and experimental development on natural sciences and engineering Watermael-Boitsfort · balance sheet €1.06m
- Biopteq Research and experimental development on natural sciences and engineering Nandrin · balance sheet 972,092 €
Frequently asked questions about Antikankerfonds-Fonds Anticancer-Anticance…
What is the revenue of Antikankerfonds-Fonds Anticancer-Anticance…?
Antikankerfonds-Fonds Anticancer-Anticance… files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Antikankerfonds-Fonds Anticancer-Anticance…?
In Belgium, the VAT number is the company number prefixed with BE: BE0535868481 for Antikankerfonds-Fonds Anticancer-Anticance…, if the company is VAT-registered. Its company number (CBE) is 0535.868.481.
Where is the registered office of Antikankerfonds-Fonds Anticancer-Anticance…?
According to the CBE register, the registered office of Antikankerfonds-Fonds Anticancer-Anticance… is in 1860 Meise.
What is the equity of Antikankerfonds-Fonds Anticancer-Anticance…?
At the close of the 2025 financial year, the equity of Antikankerfonds-Fonds Anticancer-Anticance… amounts to 5,318,167 €, a solvency of 88.8% of total assets.
How many people work at Antikankerfonds-Fonds Anticancer-Anticance…?
11.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Antikankerfonds-Fonds Anticancer-Anticance…?
The register lists 5 active mandates at Antikankerfonds-Fonds Anticancer-Anticance…. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Antikankerfonds-Fonds Anticancer-Anticance… within its sector?
By total assets for 2025, Antikankerfonds-Fonds Anticancer-Anticance… ranks among the 200 largest of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Antikankerfonds-Fonds Anticancer-Anticance…
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →